CD79a (B-Cell Marker); Clone IGA/764 (Concentrate)

Specificity: Anti-CD79a is generally used to complement anti-CD20 especially for mature B-cell lymphomas after treatment with Rituximab (anti-CD20). This antibody will stain many of the same lymphomas as anti-CD20, but also is more likely to stain B-lymphoblastic lymphoma/leukemia than is anti-CD20. Anti-CD79a also stains more cases of plasma cell myeloma and occasionally some types of endothelial cells as well.
Immunogen: Recombinant human IGA protein

• SKU: SCYRA0072-C.1
• Manufacturer: ScyTek Laboratories
• Manufacturer SKU: RA0072-C.1
• Package Unit: 0,1 ml
• Quantity Unit: STK
• Reactivity: Human
• Isotype: IgG1
• Host: Mouse